Answer
Spikevax LP.8.1 is indicated to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 6 months and older, with use in accordance with official recommendations.
Sources for this answer
- Spikevax LP.8.1 0.1 mg/mL dispersion for injectionModerna Biotech Distributor UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked